ROMO1 and neoplasm: Through the orthotopic glioblastoma mouse model, we also found that the overexpression of Romo1 in bone marrow cells inhibited the immune response within tumor microenvironment, implicating that Romo1 may also participate in the immune tolerance of tumor.